Kowa Research Institute has a strong pipeline of innovative and novel products for:
- Cardiovascular Disease
- Metabolic Disease
- Peripheral Arterial Disease
- Pain Management
Kowa’s strategy is to develop these novel compounds through proof of concept and, in selected cases, identify ideal partners for:
- Co-development
- Co-commercialization
- Licensing
The Company also considers compelling partnerships at earlier stages. If you are interested in discussing any business development opportunity, please contact:
Ian J. Mehr, Ph.D., MBA
Senior Director, Business Development
imehr@kowaus.com
Kowa Research Institute, Inc.
430 Davis Drive, Suite 200
Morrisville, NC 27560 USA
Phone: +1-919-433-1600
Fax: +1-919-433-1620